AU1398500A - Process for the production of paroxetine hydrochloride propan-2-ol solvate - Google Patents

Process for the production of paroxetine hydrochloride propan-2-ol solvate

Info

Publication number
AU1398500A
AU1398500A AU13985/00A AU1398500A AU1398500A AU 1398500 A AU1398500 A AU 1398500A AU 13985/00 A AU13985/00 A AU 13985/00A AU 1398500 A AU1398500 A AU 1398500A AU 1398500 A AU1398500 A AU 1398500A
Authority
AU
Australia
Prior art keywords
solvate
production
paroxetine hydrochloride
hydrochloride propan
propan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU13985/00A
Inventor
Andrew Simon Craig
David Alan Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of AU1398500A publication Critical patent/AU1398500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
AU13985/00A 1998-11-30 1999-11-30 Process for the production of paroxetine hydrochloride propan-2-ol solvate Abandoned AU1398500A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9826242 1998-11-30
GBGB9826242.1A GB9826242D0 (en) 1998-11-30 1998-11-30 Novel process
PCT/GB1999/004000 WO2000032597A1 (en) 1998-11-30 1999-11-30 Process for the production of paroxetine hydrochloride propan-2-ol solvate

Publications (1)

Publication Number Publication Date
AU1398500A true AU1398500A (en) 2000-06-19

Family

ID=10843335

Family Applications (1)

Application Number Title Priority Date Filing Date
AU13985/00A Abandoned AU1398500A (en) 1998-11-30 1999-11-30 Process for the production of paroxetine hydrochloride propan-2-ol solvate

Country Status (5)

Country Link
EP (1) EP1135384A1 (en)
JP (1) JP2002531454A (en)
AU (1) AU1398500A (en)
GB (1) GB9826242D0 (en)
WO (1) WO2000032597A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9828721D0 (en) 1998-12-24 1999-02-17 Glaxo Group Ltd Novel apparatus and process
DE10137017A1 (en) 2001-07-30 2003-02-20 Basf Ag Crystallization process for the adjustment of small particles
GB0711680D0 (en) 2007-06-18 2007-07-25 Prosonix Ltd Process
CN102366679A (en) * 2011-08-31 2012-03-07 华南理工大学 Horizontal spiral push-type supersonic cooling crystallization machine
WO2014137982A1 (en) 2013-03-08 2014-09-12 The Board Of Trustees Of The University Of Illinois Ultrasonic method and apparatus for producing particles having a controlled size distribution

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
AR001982A1 (en) * 1995-02-06 1998-01-07 Smithkline Beecham Plc PAROXETINE CHLORHYDRATE ANHYDRATED, AND PROCEDURE FOR ITS PREPARATION
DE69739561D1 (en) * 1996-06-13 2009-10-15 Sumitomo Chemical Co Piperidine derivatives as intermediates for the preparation of paroxetines and process for their preparation
HU221921B1 (en) * 1996-07-08 2003-02-28 Richter Gedeon Vegyészeti Gyár Rt. N-benzyl-piperidine or tetrahydro-pyridine derivatives and processes for producing them

Also Published As

Publication number Publication date
JP2002531454A (en) 2002-09-24
WO2000032597A1 (en) 2000-06-08
EP1135384A1 (en) 2001-09-26
GB9826242D0 (en) 1999-01-20

Similar Documents

Publication Publication Date Title
ZA985488B (en) Novel process for manufacturing paroxetine solid dispersions
PL348858A1 (en) Method for producing l-phenylephrine hydrochloride
AU5558800A (en) Process for the production of 2-(2-pyridinylmethylsulphinyl)-1h-benzimidazoles
AU5884700A (en) Process for making amine compounds
IL159304A0 (en) Process for the production of piperidine derivatives
AU1987400A (en) Process for preparation of paroxetine maleate
AU1398500A (en) Process for the production of paroxetine hydrochloride propan-2-ol solvate
AU7686700A (en) Process for producing microorganism-origin transglutaminase
AU1037901A (en) Process for the preparation of paroxetine
AU3818900A (en) Process for the preparation of substituted piperidines
AU1397800A (en) Method of producing paroxetine hydrochloride
HUP0105482A3 (en) Process for the production of paroxetine
AU2001238546A1 (en) Method for the production of 2-mercaptobenzothiazole
AU2002237704A1 (en) Methods for the stereoselective synthesis of substituted piperidines
AU5553200A (en) Process for the preparation of paroxetine and structurally related compounds
AU1398100A (en) Process for the production of paroxetine hydrochloride acetone solvate
AU6481799A (en) Process for the preparation of paroxetine hydrochloride
AU1396400A (en) Process for the preparation of paroxetine hydrochloride
HUP0004503A3 (en) Process for the preparation of paroxetine hydrochloride
AU3413799A (en) Process for preparing 4-substituted cis-cyclohexylamines
AU5135600A (en) Process for producing piperidine
AU5109600A (en) Process for the production of 2-pyridylpyridine derivatives
AU5550900A (en) Process for the production of paroxetine hydrochloride
AU6580800A (en) Process for the preparation of paroxetine hydrochloride
AU1396600A (en) Process for the preparation of paroxetine hydrochloride

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase